Centre Hospitalier Intercommunal Le Raincy-Monfermeil
- Address
- 10 Rue Du General Leclerc, 93370 Monfermeil, France
Centre Hospitalier Intercommunal Le Raincy-Monfermeil - Vasculitis and Ophthalmology Research
The Centre Hospitalier Intercommunal Le Raincy-Monfermeil is actively engaged in clinical research focusing on the intersection of autoimmune vasculitis and vision-threatening complications. The center demonstrates particular expertise in investigating novel therapeutic approaches for serious manifestations of systemic inflammatory conditions affecting the optic nerve.
- Giant Cell Arteritis (Horton's Disease) and its ocular complications
- Acute Anterior Ischemic Optic Neuropathy (AION) treatment optimization
- Biologic therapies including tocilizumab in vasculitic conditions
The research initiative explores innovative treatment protocols combining subcutaneous tocilizumab with conventional corticosteroid regimens to preserve visual function in patients experiencing acute vision loss. This work addresses a critical unmet need in managing Giant Cell Arteritis, where rapid and effective intervention is essential to prevent permanent blindness and improve patient outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 7 therapeutic areas and 15 of 38 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Intercommunal Le Raincy-Monfermeil
lock Showing 1 of 18 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Janssen Cilag International | Phase IV | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 38 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Prednisone | 5 | Unknown | 2020-01-27 | 2025-01-27 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.